The obtained Ki constants for both cholinesterases places it, for example, in the line with several currently investigated AD and myasthenia gravis treatment drug candidates [8,21,25,54,55,56,57,58], and as such warrants future structure refinement studies. The gene discussed is BCHE; the disease is myasthenia gravis.